Patent details

EP1915394 Title: HIGH-LEVEL EXPRESSION OF RECOMBINANT ANTIBODY IN A MAMMALIAN HOST CELL

Basic Information

Publication number:
EP1915394
PCT Application Number:
EP2006004767
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP067537456
PCT Publication Number:
WO2006122822
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIGH-LEVEL EXPRESSION OF RECOMBINANT ANTIBODY IN A MAMMALIAN HOST CELL
French Title of Invention:
EXPRESSION DE NIVEAU ELEVE D'UN ANTICORPS RECOMBINANT D'UNE CELLULE HOTE DE MAMMIFERE
German Title of Invention:
EXPRESSION AUF HOHEM NIVEAU VON REKOMBINANTEM ANTIKÖRPER IN EINER SÄUGETIER-WIRTSZELLE
SPC Number:

Dates

Filing date:
19/05/2006
Grant date:
27/01/2021
EP Publication Date:
30/04/2008
PCT Publication Date:
23/11/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/01/2021
EP B1 Publication Date:
27/01/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/05/2021
Expiration date:
19/05/2026
Renunciation date:
Revocation date:
30/12/2023
Annulment date:

Owner

From:
20/01/2021
 
 

Name:
Lonza Biologics plc.
Address:
228-230 Bath Road, Berkshire, Slough SL1 4DY, United Kingdom (GB)

Inventor

1

Name:
Rance, James
Address:
United Kingdom (GB)

2

Name:
Kalwy, Stephan
Address:
United Kingdom (GB)

3

Name:
Young, Robert
Address:
United Kingdom (GB)

4

Name:
Gay, Robert
Address:
Australia (AU)

Priority

1

Priority Number:
0510277
Priority Date:
20/05/2005
Priority Country:
United Kingdom (GB)

2

Priority Number:
0511353
Priority Date:
03/06/2005
Priority Country:
United Kingdom (GB)

3

Priority Number:
0526372
Priority Date:
28/12/2005
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
C07K 16/00;

Publication

European Patent Bulletin

1

Issue number:
202104
Publication date:
27/01/2021
Description:
Grant (B1)

2

Issue number:
202148
Publication date:
01/12/2021
Description:
Opposition procedure started

3

Issue number:
202417
Publication date:
24/04/2024
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages